Intervention not reported
Adalimumab (1 RCT; 16 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes adalimumab (1 RCT; 16 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Purine analogues (7 RCTs; 315 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes purine analogues (7 RCTs; 315 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Antibiotics (1 RCT; 16 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes antibiotics (1 RCT; 16 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Rank 5 (3 to 7) · surgically induced remission in Crohn's disease
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Placebo (10 RCTs; 531 participants) · surgically induced remission in Crohn's disease
1 finding from 1 review
Intervention not reported
Rank 4 (2 to 7) · surgically induced remission in Crohn's disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Adalimumab (2 RCTs; 26 participants) · surgically induced remission in Crohn's disease
The intervention may leads to lower adalimumab (2 RCTs; 26 participants) (low certainty).
1 finding from 1 review
Intervention not reported
Infliximab (2 RCTs; 21 participants) · surgically induced remission in Crohn's disease
It is very uncertain whether the intervention changes infliximab (2 RCTs; 21 participants) (very low certainty).
1 finding from 1 review
Intervention not reported
Budesonide (1 RCT; 43 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in budesonide (1 RCT; 43 participants) (low certainty).
1 finding from 1 review
Intervention not reported
5‐ASA (9 RCTs; 542 participants) · surgically induced remission in Crohn's disease
The intervention probably leads to lower 5‐ASA (9 RCTs; 542 participants) (moderate certainty).
1 finding from 1 review
Intervention not reported
Purine analogues (6 RCTs; 316 participants) · surgically induced remission in Crohn's disease
The intervention showed no clear difference in purine analogues (6 RCTs; 316 participants) (low certainty).
1 finding from 1 review
Remission · induction of remission in Crohn's disease
It is very uncertain whether elemental changes remission rate ‐ Intention to treat compared with non‐elemental enteral feeds (very low certainty).
1 finding from 1 review
Adverse events · induction of remission in Crohn's disease
It is very uncertain whether elemental changes adverse events compared with non‐elemental enteral feeds (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · induction of remission in Crohn's disease
It is very uncertain whether elemental changes withdrawal due to adverse events compared with non‐elemental enteral feeds (very low certainty).
1 finding from 1 review
Remission · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ ITT adult studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT adult studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ ITT pediatric studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ ITT pediatric studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Remission rate ‐ per‐protocol ‐ pediatric studies · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes remission rate ‐ per‐protocol ‐ pediatric studies compared with corticosteroids (very low certainty).
1 finding from 1 review
Adverse events · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes adverse events compared with corticosteroids (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · induction of remission in Crohn's disease
It is very uncertain whether enteral nutrition changes withdrawal due to adverse events compared with corticosteroids (very low certainty).
1 finding from 1 review